Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

$2.68 Billion Single-use Bioreactors Market 2017 by Product, Type of Molecule, Type of Cell, Type, Application, End User - Global Forecast to 2022 - Research and Markets

Research and Markets
Posted on: 05 Dec 17

The "Single-use Bioreactors Market by Product, Type of Molecule, Type of Cell, Type, Application, End User - Global Forecast to 2022" report has been added to Research and Markets' offering.

The single-use bioreactors market is expected to reach 2,685.1 million by 2022 from USD 997.6 million in 2017 at a CAGR of 21.9%

Increasing adoption of SUBs among small companies and startups and reduced automation complexity are the major factors driving the adoption of single-use bioreactors. The growing biologics market and patent expiry of many blockbuster drugs are expected to create tremendous growth opportunities for the single-use bioreactors market. On the other hand, extractability and leachability issues regarding disposable components used in bioreactors and regulatory concerns related to SUBs are the major factors restraining the growth of this market.

On the basis of product, the single-use bioreactors market is segmented into single-use bioreactor systems, media bags, filtration assemblies, and other SUBs. In 2017, single-use bioreactor systems segment is expected to account for the largest share of the single-use bioreactors market. Factors such as reduced risk of contamination and easy implementation in bioproduction are driving the adoption of SUBs.

On the basis of application, the market is classified into bioproduction, process development, and research & development. In 2017, the manufacturing services segment is expected to account for the largest share of the market. Increasing competition for new indications and the launch of biosimilars in the market are the major factors that have put pressure on manufacturers to produce biopharmaceuticals at lower costs.

The large share of North America can be attributed to increasing usage of single-use bioreactors in the R&D and process development stage as compared to other regions. Many local players are coming up with single-use products in the US with a new homegrown concept which is only prevalent in the US.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Single Use Bioreactor Market, By Product

7 Single Use Bioreactor Market, By Type

8 Single Use Bioreactor Market, By Type of Cell

9 Single Use Bioreactor Market, By Type of Molecule

10 Global Single Use Bioreactor Market, By Application

11 Global Single Use Bioreactor Market, By End User

12 Global Single Use Bioreactor Market, By Region

13 Competitive Landscape

14 Company Profiles

  • Applikon Biotechnology
  • Cellexus
  • Celltainer Biotech
  • Cesco Bioengineering
  • Danaher
  • Distek
  • Eppendorf
  • GE Healthcare
  • Merck Millipore
  • Parker Hannifin
  • PBS Biotech
  • Pierre Guerin
  • Sartorius Stedim Biotech
  • Solida Biotech
  • Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/research/t8krtx/singleuse

View source version on businesswire.com: http://www.businesswire.com/news/home/20171205006001/en/

Business Wire
www.businesswire.com

Last updated on: 05/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.